SMTI logo

SMTI
Sanara MedTech Inc

198
Mkt Cap
$157.49M
Volume
33,884.00
52W High
$35.95
52W Low
$16.05
PE Ratio
-3.96
SMTI Fundamentals
Price
$17.25
Prev Close
$17.18
Open
$17.15
50D MA
$19.76
Beta
1.38
Avg. Volume
80,439.26
EPS (Annual)
-$4.36
P/B
25.99
Rev/Employee
$954,796.13
$232.95
Loading...
Loading...
News
all
press releases
Sanara MedTech (NASDAQ:SMTI) Upgraded by Wall Street Zen to Buy Rating
Wall Street Zen upgraded Sanara MedTech from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Sanara MedTech (SMTI) to Release Quarterly Earnings on Wednesday
Sanara MedTech (NASDAQ:SMTI) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-1-sanara-medtech-inc-stock...
MarketBeat·8d ago
News Placeholder
Sanara MedTech Q4 Earnings Call Highlights
Sanara MedTech (NASDAQ:SMTI) reported fourth-quarter and full-year 2025 results highlighting record annual revenue, improved profitability, and progress in its transition to a "pure-play" surgical company following the wind-down of its Tissue Health Plus (THP) segment. Full-year results top $100 mi...
MarketBeat·9d ago
News Placeholder
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates
Sanara MedTech (SMTI) delivered earnings and revenue surprises of -63.64% and +0.53%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Sanara MedTech (NASDAQ:SMTI) Trading Up 0.8% - Here's What Happened
Sanara MedTech (NASDAQ:SMTI) Stock Price Up 0.8% - Here's Why...
MarketBeat·16d ago
News Placeholder
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates
Evolus (EOLS) delivered earnings and revenue surprises of 0.00% and +0.98%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·29d ago
News Placeholder
Sanara MedTech FY2025 EPS Forecast Boosted by HC Wainwright
Sanara MedTech Inc. (NASDAQ:SMTI - Free Report) - Research analysts at HC Wainwright upped their FY2025 EPS estimates for Sanara MedTech in a research note issued to investors on Monday, January...
MarketBeat·2mo ago
News Placeholder
HC Wainwright Reiterates Buy Rating for Sanara MedTech (NASDAQ:SMTI)
HC Wainwright restated a "buy" rating and issued a $36.00 target price on shares of Sanara MedTech in a report on Monday...
MarketBeat·2mo ago
News Placeholder
Sanara MedTech (NASDAQ:SMTI) Downgraded by Zacks Research to "Hold"
Zacks Research lowered shares of Sanara MedTech from a "strong-buy" rating to a "hold" rating in a research note on Tuesday...
MarketBeat·2mo ago
News Placeholder
Sanara MedTech (NASDAQ:SMTI) Rating Increased to Strong-Buy at Zacks Research
Zacks Research raised shares of Sanara MedTech from a "hold" rating to a "strong-buy" rating in a research note on Monday...
MarketBeat·3mo ago
<
1
2
...
>

Latest SMTI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.